Alembic Pharma gets USFDA nod

Drug firm Alembic Pharmaceuticals Monday said it has received approval from the US health regulator for Pregabalin Capsules, indicated for management of neuropathic pain associated with certain illnesses. The approved product is therapeutically equivalent to the reference listed drug Lyrica Capsules of PF Prism CV. Continue Reading

Iodine deficiency can be tackled in a simple way

“The deficiency of iodine, known as hypothyroidism, in children can lead to severe complications such as neural disorder, attention disorder, mental retardation, bone defects, stunted growth, weight gain and other metabolic disorders. It can be efficiently tackled if the mother is given sufficient amounts of the mineral during pregnancy,” added Dr Vineetha. Continue Reading